Psychemedics Inc (PMD): Long-Term Debt to Capital Ratio

The Psychemedics (PMD) price chart demonstrates the performance of a company that attracts top toxicologists and analysts due to the prestige of working with major corporations. Operations are strictly regulated by FDA standards, particularly regarding biohazardous waste processing. Meanwhile, business efficiency stands at 0.12, as the automation of sample processing during order growth significantly reduces the unit cost per test.

This ratio determines the share of long-term liabilities within the company's equity structure. It serves as a tool for assessing financial stability during long-term asset stress testing. Analyzing the dynamics of long-term loans relative to equity allows for an evaluation of financial leverage efficiency. For Psychemedics (PMD), low leverage reduces risks when scaling its proprietary testing ecosystem. High customer switching costs make such a debt strategy maximally secure.